FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 124 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $15,332,000 | +121.0% | 407,000 | +28.6% | 0.02% | +53.8% |
| Q4 2017 | $6,938,000 | -46.4% | 316,500 | 0.0% | 0.01% | -50.0% |
| Q3 2017 | $12,948,000 | +35.9% | 316,500 | 0.0% | 0.03% | +18.2% |
| Q2 2017 | $9,530,000 | -16.7% | 316,500 | 0.0% | 0.02% | -26.7% |
| Q1 2017 | $11,441,000 | -27.9% | 316,500 | 0.0% | 0.03% | -48.3% |
| Q4 2016 | $15,860,000 | -36.4% | 316,500 | -33.3% | 0.06% | -36.3% |
| Q3 2016 | $24,922,000 | +19.8% | 474,800 | -5.6% | 0.09% | +8.3% |
| Q2 2016 | $20,799,000 | +1.8% | 503,000 | 0.0% | 0.08% | 0.0% |
| Q1 2016 | $20,437,000 | -2.1% | 503,000 | 0.0% | 0.08% | -13.4% |
| Q4 2015 | $20,875,000 | – | 503,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|